Cardiovascular Systems In... (CSII)
NASDAQ: CSII
· Real-Time Price · USD
20.00
0.03 (0.15%)
At close: Apr 27, 2023, 10:00 PM
Cardiovascular Systems Balance Sheet Statement
Financials in USD. Fiscal
year is
July - June.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Cash & Equivalents | 59.84M | 62.85M | 66.42M | 66.95M | 65.86M | 66.86M | 71.07M | 75.33M | 73.78M | 92.67M |
Short-Term Investments | 72.16M | 80.9M | 93.41M | 105.1M | 110.67M | 120.75M | 135.97M | 135.73M | 151.27M | 130.27M |
Long-Term Investments | 42.03M | 34.03M | 33.42M | 30.73M | 29.67M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2.47M | 835K | 2.64M | 2.77M | 879K | 21.42M | 23.63M | 17.74M | 11.73M | 11.76M |
Receivables | 40.23M | 40.26M | 39.68M | 34.67M | 34.94M | 36.45M | 40.03M | 38.06M | 32.53M | 29.97M |
Inventory | 41.19M | 37.94M | 34.57M | 32.85M | 31.67M | 33.13M | 32.31M | 33.37M | 32.51M | 29.15M |
Other Current Assets | 8.54M | 9.13M | 7.77M | 5.74M | 4.84M | 5.94M | 5.29M | 2.85M | 2.99M | 3.37M |
Total Current Assets | 221.96M | 231.08M | 241.85M | 245.31M | 248M | 263.14M | 284.67M | 285.35M | 293.08M | 285.43M |
Property-Plant & Equipment | 30M | 30.71M | 29.04M | 29.1M | 31.43M | 30.94M | 28.89M | 28.16M | 28.12M | 28.23M |
Goodwill & Intangibles | 15.04M | 15.39M | 15.73M | 16.08M | 16.43M | 16.77M | 15.38M | 15.69M | 16M | 16.3M |
Total Long-Term Assets | 89.55M | 80.96M | 80.83M | 78.68M | 78.4M | 69.13M | 67.9M | 61.59M | 55.85M | 56.29M |
Total Assets | 311.51M | 312.04M | 322.68M | 323.99M | 326.4M | 332.27M | 352.57M | 346.94M | 348.94M | 341.72M |
Account Payables | 17.09M | 16.76M | 14.38M | 13.6M | 12.49M | 12.91M | 14.06M | 12.64M | 13.67M | 13.42M |
Deferred Revenue | 525K | 694K | 2.11M | 2.81M | 2.72M | 2.49M | 2.4M | 2.26M | 2.08M | 2.09M |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 19.15M | 19.7M | 23.46M | 30.01M | 26.67M | 27.64M | 38.19M | 35.54M | 32.34M | 30.19M |
Total Current Liabilities | 36.76M | 37.16M | 39.95M | 46.42M | 41.88M | 43.04M | 54.65M | 50.45M | 48.09M | 45.7M |
Long-Term Debt | 20.12M | 21.43M | 20.3M | 20.39M | 21.98M | 22.17M | 20.6M | 20.66M | 20.72M | 20.77M |
Other Long-Term Liabilities | 11.87M | 11.3M | 12.95M | 3.69M | 2.26M | 2.3M | 4.17M | 2.47M | 2.66M | 2.75M |
Total Long-Term Liabilities | 35.36M | 32.73M | 33.24M | 24.07M | 25M | 26.04M | 26.96M | 26.04M | 27.02M | 27.62M |
Total Liabilities | 72.12M | 69.89M | 73.2M | 70.49M | 66.88M | 69.08M | 81.61M | 76.48M | 75.1M | 73.32M |
Total Debt | 20.12M | 21.43M | 20.3M | 20.39M | 21.98M | 22.17M | 20.6M | 20.66M | 20.72M | 20.77M |
Common Stock | 40K | 40K | 40K | 39K | 39K | 39K | 39K | 39K | 39K | 39K |
Retained Earnings | -443.41M | -435.5M | -423.68M | -413.88M | -404.12M | -394.99M | -381.38M | -376.04M | -369.02M | -368.56M |
Comprehensive Income | -170K | -271K | -268K | -212K | -58K | -6K | 11K | 43K | 115K | 200K |
Shareholders Equity | 239.39M | 242.15M | 249.48M | 253.5M | 259.52M | 263.19M | 270.96M | 270.45M | 273.83M | 268.4M |
Total Investments | 114.19K | 114.92M | 126.83M | 135.83M | 140.34M | 120.75M | 135.97M | 135.73M | 151.27M | 130.27M |